Predictions
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€13.53
30.03.20
30.03.20
€29.00
04.11.21
04.11.21
72.28%
05.11.21
05.11.21
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€80.50
24.03.20
24.03.20
€180.00
04.11.21
04.11.21
127.33%
24.06.21
24.06.21
Viatris Inc.
Start price
Target price
Perf. (%)
€14.80
17.03.20
17.03.20
€16.00
04.11.21
04.11.21
0.00%
06.01.21
06.01.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
GW Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€93.00
28.02.20
28.02.20
€180.00
09.03.20
09.03.20
-15.05%
09.03.20
09.03.20
Perrigo Co. plc
Start price
Target price
Perf. (%)
€45.40
28.02.20
28.02.20
€50.00
04.11.21
04.11.21
-11.45%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Top 10 in its market
MorphoSys AG
Start price
Target price
Perf. (%)
€106.70
25.02.20
25.02.20
€61.00
04.11.21
04.11.21
-61.92%
05.11.21
05.11.21
positive Cash Flow expected
Good rating
High Investments for future growth
High valuation
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€50.50
28.01.20
28.01.20
€55.00
04.11.21
04.11.21
-23.09%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Repligen Corp.
Start price
Target price
Perf. (%)
€87.50
12.01.20
12.01.20
€155.00
04.11.21
04.11.21
170.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€109.44
27.11.19
27.11.19
-
04.11.21
04.11.21
65.25%
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Aphria Inc.
Start price
Target price
Perf. (%)
€4.29
25.11.19
25.11.19
-
04.11.21
04.11.21
196.12%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€36.04
13.09.19
13.09.19
€60.00
02.10.19
02.10.19
-9.27%
02.10.19
02.10.19
Horizon Pharma plc
Start price
Target price
Perf. (%)
€24.60
26.08.19
26.08.19
€69.00
04.11.21
04.11.21
284.63%
05.11.21
05.11.21
Swedish Orphan Biovitrum Ab
Start price
Target price
Perf. (%)
€19.49
17.07.19
17.07.19
€30.00
04.11.21
04.11.21
20.11%
05.11.21
05.11.21